Jeil Pharma Holdings (XKRX:002620) FCF Margin % : 5.25% (As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Jeil Pharma Holdings's Free Cash Flow for the three months ended in Dec. 2023 was ₩10,658 Mil. Jeil Pharma Holdings's Revenue for the three months ended in Dec. 2023 was ₩202,931 Mil. Therefore, Jeil Pharma Holdings's FCF Margin % for the quarter that ended in Dec. 2023 was 5.25%.

As of today, Jeil Pharma Holdings's current FCF Yield % is -8.25%.

The historical rank and industry rank for Jeil Pharma Holdings's FCF Margin % or its related term are showing as below:

XKRX:002620' s FCF Margin % Range Over the Past 10 Years
Min: -46.72 Med: -1.71 Max: 6.12
Current: -1.77

During the past 13 years, the highest FCF Margin % of Jeil Pharma Holdings was 6.12%. The lowest was -46.72%. And the median was -1.71%.

XKRX:002620's FCF Margin % is ranked worse than
53.94% of 1029 companies
in the Drug Manufacturers industry
Industry Median: -0.47 vs XKRX:002620: -1.77

Jeil Pharma Holdings FCF Margin % Historical Data

The historical data trend for Jeil Pharma Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings FCF Margin % Chart

Jeil Pharma Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

3.22

-4.45

-1.36

-4.88

-1.77

Jeil Pharma Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-5.43	-8.28	5.01	-9.12	5.25

Competitive Comparison of Jeil Pharma Holdings's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Jeil Pharma Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jeil Pharma Holdings's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jeil Pharma Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Jeil Pharma Holdings's FCF Margin % falls into.

Jeil Pharma Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Jeil Pharma Holdings's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-14252.258	/	804043.002
	=	-1.77 %

Jeil Pharma Holdings's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	10657.594	/	202931.172
	=	5.25 %

Jeil Pharma Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Jeil Pharma Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810

Website

https://www.jeilpharm.co.kr

Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines